New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
2
36

Melanoma Skin Cancer - The Mount Sinai Hospital

Learn more about the #risk factors, #signs, stages and advanced #treatments for melanoma skin cancer. Visit our #Skin #Cancer Center at http://www.mountsinai.org/skincancer #infographic #Health #Medical #Medicine #treatment #HealthyTips #Wellness |Skin Cancer, Cancer and Infographic.  
uk.pinterest.com
over 3 years ago
Preview
0
1

Indoor Tanning Linked to Melanoma Among Young Women

Indoor tanning may explain why U.S. melanoma rates are rising faster for women than for men, according to new research.  
medscape.com
over 3 years ago
Preview
0
0

Scientists Watch as Healthy Cells Turn Into Melanoma

Harvard researchers have engineered zebrafish to track melanoma as it begins with its initiation from neural crest progenitor-like cells. Can these observations help stop cancer before it even begins?  
medscape.com
over 3 years ago
Preview
0
0

Melanoma Genetics

What do we know regarding the genetic basis of familial melanoma? Learn the status of current research in this review.  
medscape.com
over 3 years ago
Preview
0
0

Most melanoma patients have few moles, study finds

Patients with melanoma tend to have few moles, and these are rarely atypical, research published in JAMA Dermatology has found.1  
feeds.bmj.com
over 3 years ago
Preview
0
0

Treating Melanoma Brain Mets With Radiation and Nivolumab

Is stereotactic radiation to melanoma brain metastases tolerated well in patients who received nivolumab?  
medscape.com
over 3 years ago
Preview
0
1

EMA Panel Likes Combo Immunotherapy for Melanoma

The immunotherapy combination of nivolumab and ipilimumab is for patients with advanced disease.  
medscape.com
over 3 years ago
Preview
0
0

Variants of 'Redhead' Gene Up Melanoma Risk Even Without Sun

Inheriting certain MC1R variants doubled the risk of developing melanoma, independent of sun exposure.  
medscape.com
over 3 years ago
Preview
0
0

Skin cancer: Pair of drugs 'eliminate 20% of tumours' - BBC News

A fifth of people with advanced melanoma have no sign of tumours in their body after treatment with a pair of immunotherapy drugs, a study shows.  
bbc.co.uk
over 3 years ago
Preview
0
0

Downside to Melanoma Immunotherapy: 55% to 67% Nonresponders

The efficacy of anti-PD-1 agents for advanced melanoma, such as pembrolizumab, has been great news, but not for all patients.  
medscape.com
over 3 years ago
Preview
0
0

Differentiating Spitz Naevi From Melanoma

Spitz naevi and melanomas may show overlapping dermoscopic patterns, making them challenging to differentiate. Can reflectance confocal microscopy improve diagnostic accuracy?  
medscape.com
over 3 years ago
Preview
0
2

Melanoma: Survival Curve 'Tail' Getting Longer

Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016.  
medscape.com
over 3 years ago
Preview
0
0

microRNA-10b Is a Prognostic Biomarker for Melanoma

The authors sought to identify which microRNAs might have prognostic value in melanoma. Is there a place for microRNA analysis in stratifying melanoma for therapy?  
medscape.com
over 3 years ago
Preview
0
0

Researchers Make Progress in Unraveling Uveal Melanoma

Two studies from the University of Miami Miller School of Medicine shed light on physiological and genetic factors associated with uveal melanoma (UM).  
medscape.com
over 3 years ago
Preview
0
1

Drugs for Multiple Myeloma, Melanoma Approved in Europe

The European approvals are for elotuzumab (multiple myeloma) and nivolumab in combination with ipilimumab (advanced melanoma).  
medscape.com
over 3 years ago
Preview
0
1

BRAF Inhibitor Improves Radiosurgery Outcomes in Melanoma

BRAF-carrying patients with melanoma and brain metastases treated with BRAF inhibitors and SRS show improved survival, but timing of treatment matters.  
medscape.com
over 3 years ago
Preview
0
1

Plasma Cells in Primary Melanoma

This study aimed to characterize the pathological features and clinical outcome of primary cutaneous melanomas associated with plasma cells.  
medscape.com
over 3 years ago
Preview
0
1

Skin cancer: Drug gives '40% melanoma survival' - BBC News

Four in 10 skin cancer patients given a drug to boost their immune were still alive after three years, a study suggests.  
bbc.co.uk
over 3 years ago
Preview
0
2

One Honest Researcher and More Talk of Cure for Melanoma

During a press conference, a pembrolizumab investigator was open and honest about comparisons with rival immunotherapy nivolumab and her hope for some special patients.  
medscape.com
over 3 years ago
Preview
0
1

Nivolumab for Metastatic Melanoma

This brief profile gives an overview of nivolumab, a human monoclonal antibody against PD-1 receptor, approved for treatment of unresectable or metastatic melanoma that is unresponsive to other drugs.  
medscape.com
over 3 years ago